======= GPI ======= == Gene Information == * **Official Symbol**: GPI * **Official Name**: glucose-6-phosphate isomerase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2821|2821]] * **UniProt**: [[https://www.uniprot.org/uniprot/P06744|P06744]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GPI&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GPI|Open PubMed]] * **OMIM**: [[https://omim.org/entry/172400|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the glucose phosphate isomerase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In the cytoplasm, the gene product functions as a glycolytic enzyme (glucose-6-phosphate isomerase) that interconverts glucose-6-phosphate and fructose-6-phosphate. Extracellularly, the encoded protein (also referred to as neuroleukin) functions as a neurotrophic factor that promotes survival of skeletal motor neurons and sensory neurons, and as a lymphokine that induces immunoglobulin secretion. The encoded protein is also referred to as autocrine motility factor based on an additional function as a tumor-secreted cytokine and angiogenic factor. Defects in this gene are the cause of nonspherocytic hemolytic anemia and a severe enzyme deficiency can be associated with hydrops fetalis, immediate neonatal death and neurological impairment. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]. * **UniProt Summary**: Besides it's role as a glycolytic enzyme, mammalian GPI can function as a tumor-secreted cytokine and an angiogenic factor (AMF) that stimulates endothelial cell motility. GPI is also a neurotrophic factor (Neuroleukin) for spinal and sensory neurons. {ECO:0000269|PubMed:11004567, ECO:0000269|PubMed:11437381}. |PGI| |glucose-6-phosphate isomerase activity| |intramolecular transferase activity| |positive regulation of immunoglobulin secretion| |monosaccharide binding| |regulation of immunoglobulin secretion| |glucose 6-phosphate metabolic process| |canonical glycolysis| |NADH regeneration| |glucose catabolic process to pyruvate| |glycolytic process through fructose-6-phosphate| |glycolytic process through glucose-6-phosphate| |glucose catabolic process| |NADH metabolic process| |glycolytic process| |ATP generation from ADP| |positive regulation of immunoglobulin production| |gluconeogenesis| |NAD metabolic process| |hexose biosynthetic process| |ADP metabolic process| |hexose catabolic process| |monosaccharide biosynthetic process| |nucleoside diphosphate phosphorylation| |purine nucleoside diphosphate metabolic process| |monosaccharide catabolic process| |purine ribonucleoside diphosphate metabolic process| |nucleotide phosphorylation| |ribonucleoside diphosphate metabolic process| |regulation of immunoglobulin production| |pyruvate metabolic process| |nucleoside diphosphate metabolic process| |positive regulation of production of molecular mediator of immune response| |positive regulation of endothelial cell migration| |glucose metabolic process| |secretory granule lumen| |carbohydrate catabolic process| |ficolin-1-rich granule lumen| |carbohydrate biosynthetic process| |regulation of production of molecular mediator of immune response| |positive regulation of epithelial cell migration| |hexose metabolic process| |regulation of endothelial cell migration| |growth factor activity| |cytokine activity| |monosaccharide metabolic process| |ATP metabolic process| |positive regulation of immune effector process| |regulation of epithelial cell migration| |positive regulation of protein secretion| |positive regulation of peptide secretion| |ubiquitin protein ligase binding| |hemostasis| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |humoral immune response| |purine-containing compound metabolic process| |positive regulation of secretion by cell| |generation of precursor metabolites and energy| |positive regulation of protein transport| |positive regulation of secretion| |small molecule catabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |positive regulation of establishment of protein localization| |regulation of protein secretion| |regulation of immune effector process| |carbohydrate metabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |regulation of peptide secretion| |regulation of body fluid levels| |neutrophil mediated immunity| |positive regulation of cell migration| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |positive regulation of cell motility| |myeloid cell activation involved in immune response| |monocarboxylic acid metabolic process| |positive regulation of cellular component movement| |nucleobase-containing small molecule metabolic process| |positive regulation of locomotion| |myeloid leukocyte activation| |small molecule biosynthetic process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |leukocyte mediated immunity| |exocytosis| |regulation of secretion| |regulation of cell migration| |organophosphate metabolic process| |carboxylic acid metabolic process| |regulation of cell motility| |leukocyte activation| |oxidation-reduction process| |regulation of locomotion| |positive regulation of transport| |regulation of cellular component movement| |oxoacid metabolic process| |secretion by cell| |organic acid metabolic process| |regulation of protein localization| |carbohydrate derivative metabolic process| |export from cell| |cell activation| |immune effector process| |secretion| |positive regulation of immune system process| |phosphorylation| |regulation of immune system process| |positive regulation of multicellular organismal process| |small molecule metabolic process| |organic substance catabolic process| |regulation of transport| |immune response| |extracellular region| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp438|NN-Diethyl-meta-toluamide 500μM R08 exp438]]|-3.02| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|-2.15| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-2.11| |[[:results:exp534|Trientine 500μM R08 exp534]]|-1.9| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-1.89| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|-1.87| |[[:results:exp212|Phenformin 20μM R05 exp212]]|-1.82| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|-1.76| |[[:results:exp480|ETC-159 50μM R08 exp480]]|-1.74| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|-1.73| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|-1.71| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.76| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|1.77| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|1.79| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.79| |[[:results:exp512|Olaparib 4μM R08 exp512]]|1.81| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|1.89| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|1.9| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.91| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|1.96| |[[:results:exp539|42°C R08 exp539]]|1.97| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|2| |[[:results:exp90|WYE-354 6μM R02 exp90]]|2.08| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.15| |[[:results:exp211|AICAR 240μM R05 exp211]]|2.27| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.57| |[[:results:exp360|Genistein 15μM R07 exp360]]|2.93| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|2.97| |[[:results:exp79|Q15 2.7μM R02 exp79]]|3.63| |[[:results:exp264|Arsenate 40μM R06 exp264]]|3.84| ^Gene^Correlation^ |[[:human genes:h:hk2|HK2]]|0.624| |[[:human genes:p:pgp|PGP]]|0.578| |[[:human genes:s:slc2a1|SLC2A1]]|0.538| |[[:human genes:p:pgls|PGLS]]|0.514| |[[:human genes:p:pfkp|PFKP]]|0.512| |[[:human genes:c:crls1|CRLS1]]|0.436| |[[:human genes:a:ahcyl1|AHCYL1]]|0.424| |[[:human genes:t:tkt|TKT]]|0.422| |[[:human genes:r:romo1|ROMO1]]|0.402| Global Fraction of Cell Lines Where Essential: 39/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|1/28| |bone|1/26| |breast|0/33| |central nervous system|3/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|2/16| |kidney|4/21| |liver|2/20| |lung|5/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|2/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 37 * **Expression level (log2 read counts)**: 8.18 {{:chemogenomics:nalm6 dist.png?nolink |}}